Drug Co. Says Exclusion Doesn't Bar Subpoena Coverage

By Emily Enfinger · August 28, 2023, 3:17 PM EDT

A drug development company born out of a merger is once again seeking coverage for expenses it advanced to two of its former officers in connection with U.S. Securities and Exchange...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Motion

Case Information

Case Title

Amtrust International Underwriters DAC v. 180 Life Sciences Corp.

Case Number

Court

California Northern

Nature of Suit

Insurance

Date Filed

June 29, 2022

Recent Articles By Emily

February 08, 2024
Broker Hit With Suit Over Data Breach Affecting 1.5 Million
February 06, 2024
Appeals Court Upholds Insurers' COVID-19 Coverage Win
January 11, 2024
Nationwide Wins Dismissal After Pruning Billing Class Action
January 05, 2024
Insurers Can't Reargue In Ex-Xerox Unit Coverage Row
December 18, 2023
3rd Circ. Tosses Insurer Win In Nursing Home Coverage Row
October 23, 2023
Insurer Drops Sperm Bank Customers From Coverage Dispute
September 18, 2023
Lab Says BCBS Unit Owes Millions For COVID-19 Test Claims
September 18, 2023
Insurer Escapes Coverage Bid In Wrongful Death Suit
September 12, 2023
Geico Accuses Fla. Chiropractic Clinic Of $8M No-Fault Scam
September 11, 2023
NJ Lab Says Alliant Owes Payment For COVID-19 Testing